Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CRDFCardiff Oncology, Inc.

Nasdaq · CIK 0001213037
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts377

Identity from submissions API

NameCardiff Oncology, Inc.
CIK0001213037
TickersCRDF
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN272004382
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone858-952-7570
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Trovagene, Inc. (2013-03-27T04:00:00.000Z → 2020-05-07T04:00:00.000Z)
  • TrovaGene Inc. (2011-11-25T05:00:00.000Z → 2013-03-04T05:00:00.000Z)
  • XENOMICS INC (2004-07-19T04:00:00.000Z → 2009-06-03T04:00:00.000Z)
  • USED KAR PARTS INC (2003-01-07T05:00:00.000Z → 2004-06-30T04:00:00.000Z)
Business address
11055 FLINTKOTE AVENUE
SAN DIEGO
CA
92121
CA
Mailing address
11055 FLINTKOTE AVENUE
SAN DIEGO
CA
92121
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1199 filing rows loaded from submissions recent; extra archives: CIK0001213037-submissions-001.json (199 filings, 2003-01-07 to 2012-05-22).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-007934 005-80378 261555724 34 9513
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-458500 001-35558 261547361 34 434210 1 1
2026-11-12 10-Q 10-Q 0001193125-26-458485 001-35558 261547324 34 9035177 1 1
2026-10-27 3 3 0001493152-26-048722 3376
2026-10-27 8-K 8-K 5.02,5.03,7.01,9.01 0001493152-26-048720 001-35558 261491135 34 249460 1 1
2026-10-22 8-K 8-K 5.07 0001493152-26-048111 001-35558 261479168 34 200332 1 1
2026-09-14 8-K 8-K 1.01,7.01,9.01 0001493152-26-042506 001-35558 261376026 34 370279 1 1
2026-08-26 DEFA14A DEFA14A 0001193125-26-368287 001-35558 261322664 34 108706
2026-08-26 DEF 14A DEF 14A 0001193125-26-368249 001-35558 261322532 34 261812
2026-08-14 PRE 14A PRE 14A 0001193125-26-352135 001-35558 261280889 34 253354
2026-08-11 8-K 8-K 2.02,9.01 0001193125-26-344645 001-35558 261263300 34 441450 1 1
2026-08-11 10-Q 10-Q 0001193125-26-344545 001-35558 261263050 34 8878884 1 1
2026-07-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002222 005-80378 261206085 34 11011
2026-07-21 S-8 S-8 0001193125-26-310273 333-297589 261190182 33 479022 1 1
2026-07-16 4 4 0001193125-26-306083 7468
2026-07-16 4 4 0001193125-26-306072 7555
2026-07-16 8-K 8-K 1.01,8.01,9.01 0001193125-26-305467 001-35558 261178755 34 1047539 1 1
2026-07-16 424B5 424B5 0001193125-26-305465 333-285327 261178754 33 1134886
2026-06-22 4 4 0001664708-26-000002 4775
2026-06-22 4 4 0001184778-26-000009 4684
2026-06-15 4 4 0001370087-26-000005 5328
2026-06-15 4 4 0001635493-26-000002 5346
2026-06-15 4 4 0001543174-26-000005 5321
2026-06-15 4 4 0001393415-26-000002 5358
2026-06-15 4 4 0001184778-26-000007 5312
2026-06-11 8-K 8-K 5.07 0001193125-26-267563 001-35558 261083217 34 210316 1 1
2026-06-03 8-K 8-K 7.01 0001193125-26-254658 001-35558 261059020 34 11235146 1 1
2026-05-29 8-K 8-K 1.01 0001193125-26-248711 001-35558 261045954 34 146668 1 1
2026-05-19 8-K 8-K 8.01 0001193125-26-231040 001-35558 261000047 34 145756 1 1
2026-05-14 8-K 8-K 2.02,9.01 0001213037-26-000013 001-35558 26979122 34 378829 1 1
2026-05-14 10-Q 10-Q 0001213037-26-000011 001-35558 26978509 34 7148898 1 1
2026-04-28 4 4 0002132312-26-000004 5550
2026-04-28 3 3 0002132312-26-000003 3290
2026-04-23 DEFA14A DEFA14A 0001213037-26-000007 001-35558 26889328 34 429229
2026-04-23 DEF 14A DEF 14A 0001213037-26-000006 001-35558 26889315 34 2982633 1 1
2026-04-23 ARS ARS 0001213037-26-000004 001-35558 26889283 34 955670
2026-04-16 3 3 0001651911-26-000008 3912
2026-04-16 4/A 4/A 0001651911-26-000006 5561
2026-04-16 4 4 0001904824-26-000002 5488
2026-04-16 4 4 0001651911-26-000004 6100
2026-04-09 8-K 8-K 5.02,8.01,9.01 0001193125-26-149623 001-35558 26851681 34 194330 1 1
2026-04-02 4 4 0001193125-26-140164 5553
2026-04-02 8-K 8-K 1.01,5.02 0001193125-26-140152 001-35558 26833724 34 149240 1 1
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000835 005-80378 26798899 34 7376
2026-02-25 8-K 8-K 7.01,9.01 0001193125-26-068668 001-35558 26674334 34 17225940 1 1
2026-02-24 8-K 8-K 2.01,9.01 0001193125-26-067476 001-35558 26672870 34 369670 1 1
2026-02-24 10-K 10-K 0001193125-26-067464 001-35558 26672837 34 11477766 1 1
2026-02-18 4 4 0002110286-26-000005 5362
2026-02-18 4 4 0001193125-26-056994 5257
2026-02-09 3 3 0002110286-26-000003 12627
2026-01-27 8-K 8-K 5.02,8.01,9.01 0001193125-26-024375 001-35558 26565320 34 295056 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001193125-25-269492 001-35558 251458283 34 428190 1 1
2025-11-06 10-Q 10-Q 0001193125-25-269424 001-35558 251458023 34 7574230 1 1
2025-08-28 S-8 S-8 0001213037-25-000008 333-289921 251274403 33 852225 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001831942-25-000010 005-80378 251220818 34 11181
2025-07-31 4 4 0000950170-25-100882 6040
2025-07-29 8-K 8-K 2.02,7.01,8.01 0000950170-25-099631 001-35558 251161960 34 26797819 1 1
2025-07-29 10-Q 10-Q 0000950170-25-099610 001-35558 251161687 34 7291752 1 1
2025-07-29 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000829 005-80378 251159129 34 6374
2025-07-08 3 3 0000950170-25-094580 4584
2025-06-30 4 xslF345X05/ownership.xml 0001641172-25-017072 5392
2025-06-30 4 xslF345X05/ownership.xml 0001641172-25-017071 5428
2025-06-30 4 xslF345X05/ownership.xml 0001641172-25-017070 5414
2025-06-27 4 xslF345X05/ownership.xml 0001641172-25-017005 5404
2025-06-27 4 xslF345X05/ownership.xml 0001641172-25-016989 5419
2025-06-27 4 xslF345X05/ownership.xml 0001641172-25-016987 5388
2025-06-26 8-K 8-K 5.07 0001641172-25-016659 001-35558 251080840 34 216849 1 1
2025-06-17 8-K 8-K 5.02,8.01,9.01 0000950170-25-087369 001-35558 251053481 34 356478 1 1
2025-05-13 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001552 333-285327 25942431 33 2004
2025-05-12 CORRESP filename1.htm 0000950170-25-069253 18661
2025-05-08 S-3/A S-3/A 0000950170-25-066968 333-285327 25926242 33 1077425
2025-05-08 8-K 8-K 2.02,9.01 0000950170-25-066947 001-35558 25926128 34 368181 1 1
2025-05-08 10-Q 10-Q 0000950170-25-066886 001-35558 25925789 34 6393623 1 1
2025-04-30 DEFA14A DEFA14A 0000950170-25-061003 001-35558 25894711 34 2600155
2025-04-29 ARS ARS 0000950170-25-060092 001-35558 25887097 34 559955
2025-04-29 DEF 14A DEF 14A 0000950170-25-060074 001-35558 25886935 34 4320378 1 1
2025-04-23 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-001480 005-80378 25863213 34 10938
2025-03-13 4 4 0000950170-25-038717 5546
2025-03-13 4 4 0000950170-25-038708 5517
2025-03-13 4 4 0000950170-25-038698 5480
2025-03-13 4 4 0000950170-25-038694 5534
2025-03-06 UPLOAD filename1.pdf 0000000000-25-002483 333-285327 40280
2025-02-27 8-K 8-K 2.02,9.01 0000950170-25-029065 001-35558 25678981 34 438187 1 1
2025-02-27 S-3 S-3 0000950170-25-029044 333-285327 25678860 33 2253092
2025-02-27 10-K 10-K 0000950170-25-028992 001-35558 25678485 34 10418592 1 1
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000078003-25-000040 005-80378 25614293 34 7094
2025-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-001468 005-80378 25594566 34 11959
2025-01-06 8-K 8-K 5.03,9.01 0000950170-25-002076 001-35558 25511160 34 345725 1 1
2024-12-18 4 4 0000950170-24-137938 7695
2024-12-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-24-050401 005-80378 241555674 34 16078
2024-12-16 4 4 0000950170-24-136725 4563
2024-12-12 4 4 0000950170-24-135767 6045
2024-12-11 424B5 424B5 0000950170-24-135144 333-264148 241540066 33 1322939
2024-12-10 8-K 8-K 1.01,8.01,9.01 0000950170-24-134970 001-35558 241538572 34 862969 1 1
2024-12-10 8-K 8-K 7.01,8.01,9.01 0000950170-24-134749 001-35558 241537004 34 12802542 1 1
2024-11-08 SC 13G us14147l1089_110824.txt 0002012383-24-003492 005-80378 241439624 34 13874
2024-11-07 8-K 8-K 2.02,9.01 0000950170-24-123303 001-35558 241435595 34 418610 1 1
2024-11-07 10-Q 10-Q 0000950170-24-123242 001-35558 241435343 34 5965288 1 1
2024-10-24 SC 13G us14147l1089_102424.txt 0002012383-24-002184 005-80378 241392107 34 13862
2024-08-08 8-K 8-K 2.02,9.01 0001628280-24-036122 001-35558 241188245 34 287341 1 1
2024-08-08 10-Q 10-Q 0001628280-24-036098 001-35558 241188002 34 4326908 1 1
2024-07-01 4 FORM 4 0001628280-24-030643 5363
2024-07-01 4 FORM 4 0001628280-24-030642 5338
2024-07-01 4 FORM 4 0001628280-24-030641 5358
2024-07-01 4 FORM 4 0001628280-24-030640 5329
2024-07-01 4 FORM 4 0001628280-24-030638 5345
2024-07-01 4 FORM 4 0001628280-24-030636 5372
2024-07-01 S-8 S-8 0001628280-24-030627 333-280623 241090472 33 369248
2024-06-20 8-K 8-K 5.07 0001628280-24-029108 001-35558 241056155 34 185146 1 1
2024-06-17 DEFA14A DEFA14A 0001104659-24-071955 001-35558 241046890 34 13637
2024-06-03 DEFA14A DEFA14A 0001628280-24-026307 001-35558 241013621 34 18858
2024-06-03 8-K 8-K 5.03,8.01,9.01 0001628280-24-026295 001-35558 241013537 34 167172 1 1
2024-05-02 8-K 8-K 2.02,9.01 0001628280-24-020010 001-35558 24908298 34 283377 1 1
2024-05-02 10-Q 10-Q 0001628280-24-019974 001-35558 24907968 34 3905295 1 1
2024-04-25 DEFA14A DEFA14A 0001628280-24-018171 001-35558 24876381 34 669101
2024-04-25 ARS ARS 0001628280-24-018164 001-35558 24876304 34 806236
2024-04-25 DEF 14A DEF 14A 0001628280-24-018143 001-35558 24876113 34 1702763 1 1
2024-04-08 8-K 8-K 7.01,9.01 0001628280-24-015247 001-35558 24829646 34 383248 1 1
2024-03-27 S-8 S-8 0001628280-24-013289 333-278266 24790518 33 258883
2024-03-07 4 FORM 4 0001628280-24-009748 5633
2024-03-07 4 FORM 4 0001628280-24-009747 5663
2024-03-07 4 FORM 4 0001628280-24-009746 5597
2024-03-07 4 FORM 4 0001628280-24-009745 5652
2024-02-29 8-K 8-K 2.02,7.01,9.01 0001628280-24-007972 001-35558 24703633 34 4809774 1 1
2024-02-29 10-K 10-K 0001628280-24-007948 001-35558 24703394 34 6974696 1 1
2024-02-06 SC 13G/A CARDIFF ONCOLOGY, INC. 0000902664-24-001100 005-80378 24600157 34 77089
2024-01-08 8-K 8-K 7.01,9.01 0001628280-24-000780 001-35558 24518625 34 8137087 1 1
2023-12-19 4 FORM 4 0001628280-23-042045 4694
2023-11-14 4 FORM 4 0001628280-23-038955 4975
2023-11-02 8-K 8-K 2.02,7.01,9.01 0001628280-23-036386 001-35558 231372244 34 1502208 1 1
2023-11-02 10-Q 10-Q 0001628280-23-036375 001-35558 231372070 34 4492971 1 1
2023-09-26 8-K 8-K 7.01,8.01,9.01 0001628280-23-033014 001-35558 231280542 34 3335646 1 1
2023-08-09 8-K 8-K 2.02,5.03,9.01 0001628280-23-028563 001-35558 231155134 34 314345 1 1
2023-08-09 10-Q 10-Q 0001628280-23-028549 001-35558 231154970 34 5176305 1 1
2023-08-07 8-K FORM 8-K 7.01,8.01,9.01 0001104659-23-088391 001-35558 231148151 34 6669093 1 1
2023-07-24 8-K 8-K 8.01,9.01 0001628280-23-025483 001-35558 231105818 34 192878 1 1
2023-06-20 8-K 8-K 8.01,9.01 0001628280-23-022757 001-35558 231026457 34 195696 1 1
2023-06-20 4 FORM 4 0001628280-23-022742 5293
2023-06-20 4 FORM 4 0001628280-23-022738 5263
2023-06-20 4 FORM 4 0001628280-23-022736 5281
2023-06-20 4 FORM 4 0001628280-23-022734 5247
2023-06-20 4 FORM 4 0001628280-23-022732 5275
2023-06-20 4 FORM 4 0001628280-23-022731 5255
2023-06-15 8-K 8-K 5.07 0001628280-23-022271 001-35558 231018040 34 206785 1 1
2023-05-04 8-K 8-K 2.02,9.01 0001628280-23-015693 001-35558 23888486 34 292615 1 1
2023-05-04 10-Q 10-Q 0001628280-23-015692 001-35558 23888447 34 4932468 1 1
2023-04-27 ARS ARS 0001628280-23-013562 001-35558 23856645 34 725135
2023-04-27 DEFA14A DEFA14A 0001628280-23-013560 001-35558 23856618 34 2952810
2023-04-27 DEF 14A DEF 14A 0001628280-23-013558 001-35558 23856570 34 1372376 1 1
2023-03-16 4 FORM 4 0001628280-23-008357 5527
2023-03-16 4 FORM 4 0001628280-23-008356 5563
2023-03-16 4 FORM 4 0001628280-23-008355 5532
2023-03-16 4 FORM 4 0001628280-23-008354 5582
2023-03-10 8-K 8-K 7.01 0001628280-23-007567 001-35558 23724424 34 173712 1 1
2023-03-02 8-K 8-K 2.02,9.01 0001628280-23-006049 001-35558 23699083 34 332782 1 1
2023-03-02 10-K 10-K 0001628280-23-006037 001-35558 23698727 34 8308484 1 1
2023-02-14 SC 13G/A d9940188_13g-a.htm 0000919574-23-001496 005-80378 23625856 34 133808
2023-02-09 3 FORM 3 0001628280-23-002987 4565
2023-02-09 SC 13G/A JHG PLC OWNS <5% 0001274173-23-000005 005-80378 23601593 34 10261
2023-02-02 8-K 8-K 5.02,8.01,9.01 0001628280-23-002037 001-35558 23580787 34 339589 1 1
2023-01-26 SC 13G CARDIFF ONCOLOGY, INC. 0000902664-23-000735 005-80378 23556685 34 82996
2023-01-26 SC 13D/A CARDIFF ONCOLOGY, INC. 0000902664-23-000734 005-80378 23556674 34 84813
2022-11-29 4 FORM 4 0001628280-22-030946 4703
2022-11-03 8-K 8-K 2.02,9.01 0001628280-22-028200 001-35558 221358178 34 348347 1 1
2022-11-03 10-Q 10-Q 0001628280-22-028164 001-35558 221357785 34 5690399 1 1
2022-10-11 4 FORM 4 0001628280-22-026245 5014
2022-10-03 8-K 8-K 7.01,9.01 0001628280-22-025855 001-35558 221287622 34 8576628 1 1
2022-09-20 4 FORM 4 0001628280-22-025265 5176
2022-09-19 4 FORM 4 0001628280-22-025101 6032
2022-09-19 4 FORM 4 0001628280-22-025100 5027
2022-09-19 4 FORM 4 0001628280-22-025099 5050
2022-09-12 8-K 8-K 7.01,8.01,9.01 0001628280-22-024744 001-35558 221238661 34 7131979 1 1
2022-09-06 8-K 8-K 8.01,9.01 0001628280-22-024362 001-35558 221228332 34 230270 1 1
2022-08-04 8-K 8-K 2.02,9.01 0001628280-22-021064 001-35558 221136584 34 766365 1 1
2022-08-04 10-Q 10-Q 0001628280-22-021044 001-35558 221136393 34 5364088 1 1
2022-07-12 S-8 S-8 0001628280-22-018845 333-266103 221079211 33 539365
2022-07-08 SC 13G us14147l1089_070822.txt 0000834237-22-010217 005-80378 221074986 34 12381
2022-07-06 4 FORM 4 0001628280-22-018607 6817
2022-06-14 8-K/A 8-K/A 5.07 0001628280-22-017114 001-35558 221014810 34 632585 1 1
2022-06-09 4 FORM 4 0001628280-22-016731 22478
2022-06-09 8-K 8-K 5.07 0001628280-22-016711 001-35558 221006715 34 630556 1 1
2022-05-05 8-K 8-K 2.02,9.01 0001628280-22-012620 001-35558 22896090 34 769049 1 1
2022-05-05 10-Q 10-Q 0001628280-22-012614 001-35558 22896006 34 4872573 1 1
2022-04-25 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-04-25 16:00:00 9999999995-22-001079 333-264148 22851601 33 1962
2022-04-21 CORRESP filename1.htm 0001628280-22-009849 9877
2022-04-15 DEFA14A DEFA14A 0001628280-22-009282 001-35558 22829525 34 2528825
2022-04-14 DEF 14A DEF 14A 0001628280-22-009196 001-35558 22827221 34 618960
2022-04-14 UPLOAD filename1.pdf 0000000000-22-004028 40385
2022-04-12 8-K 8-K 5.02,7.01,9.01 0001628280-22-008987 001-35558 22822402 34 655885 1 1
2022-04-08 8-K 8-K 7.01,9.01 0001628280-22-008804 001-35558 22816803 34 712297 1 1
2022-04-05 S-3 S-3 0001628280-22-008431 333-264148 22808175 33 1576841
2022-03-11 4 FORM 4 0001628280-22-005854 5297
2022-03-10 4 FORM 4 0001628280-22-005797 5331
2022-03-10 4 FORM 4 0001628280-22-005796 5306
2022-03-10 4 FORM 4 0001628280-22-005795 5455
2022-03-10 4 FORM 4 0001628280-22-005794 5326
2022-03-10 4 FORM 4 0001628280-22-005793 5342
2022-03-10 4 FORM 4 0001628280-22-005792 5462
2022-03-10 4 FORM 4 0001628280-22-005791 5431
2022-03-10 4 FORM 4 0001628280-22-005790 5481
2022-03-10 4 FORM 4 0001628280-22-005789 5345
2022-03-10 4 FORM 4 0001628280-22-005788 5313
2022-02-24 8-K 8-K 2.02,9.01 0001628280-22-003816 001-35558 22671002 34 778544 1 1
2022-02-24 10-K 10-K 0001628280-22-003808 001-35558 22670782 34 8640402 1 1
2022-02-14 SC 13G/A d9177405_13g-a.htm 0000919574-22-001586 005-80378 22632014 34 132604
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-022672 005-80378 22631288 34 91815
2022-02-14 SC 13G/A d9178686_13g-a.htm 0000919574-22-001063 005-80378 22623736 34 165411
2022-02-10 SC 13G/A JANUS HENDERSON GROUP PLC OWNS >5% 0001274173-22-000023 005-80378 22613182 34 10783
2022-02-09 SC 13G/A CARDIFF_ONCOLOGY_INC.txt 0000093751-22-000021 005-80378 22605274 34 8564
2022-02-04 SC 13G us14147l1089_020422.txt 0000834237-22-007266 005-80378 22593480 34 13335
2022-01-31 8-K 8-K 8.01,9.01 0001628280-22-001522 001-35558 22575336 34 643492 1 1
2022-01-18 8-K 8-K 7.01,9.01 0001628280-22-001039 001-35558 22535819 34 4775492 1 1
2022-01-14 3 FORM 3 0001628280-22-000933 4527
2022-01-11 8-K 8-K 8.01,9.01 0001628280-22-000669 001-35558 22522984 34 661086 1 1
2021-12-10 8-K 8-K 8.01,9.01 0001628280-21-024814 001-35558 211484305 34 650096 1 1
2021-12-03 8-K 8-K 8.01,9.01 0001628280-21-024493 001-35558 211469074 34 648926 1 1
2021-11-19 SC 13G SC 13G CARDIFF ONCOLOGY INC. 0000078003-21-000112 005-80378 211428304 34 35961
2021-11-18 424B5 424B5 0001628280-21-023781 333-254217 211422969 33 703523
2021-11-18 8-K 8-K 1.01,9.01 0001628280-21-023776 001-35558 211422706 34 1105296 1 1
2021-11-10 8-K 8-K 8.01,9.01 0001628280-21-022729 001-35558 211395654 34 852501 1 1
2021-11-04 8-K 8-K 2.02,9.01 0001628280-21-021748 001-35558 211379798 34 976527 1 1
2021-11-04 10-Q 10-Q 0001628280-21-021747 001-35558 211379767 34 6254384 1 1
2021-09-22 4 FORM 4 0001628280-21-019057 4663
2021-09-13 4 FORM 4 0001628280-21-018433 10131
2021-09-08 8-K 8-K 7.01,9.01 0001628280-21-018216 001-35558 211242014 34 7080324 1 1
2021-09-07 8-K 8-K 8.01,9.01 0001628280-21-018136 001-35558 211238640 34 696983 1 1
2021-08-25 8-K 8-K 8.01,9.01 0001628280-21-017578 001-35558 211205649 34 705164 1 1
2021-08-05 10-Q 10-Q 0001628280-21-015834 001-35558 211148075 34 6256785 1 1
2021-08-05 8-K 8-K 2.02,9.01 0001628280-21-015831 001-35558 211148042 34 987170 1 1
2021-07-14 4 FORM 4 0001628280-21-013826 5484
2021-07-13 3 FORM 3 0001628280-21-013784 3302
2021-07-12 4 FORM 4 0001628280-21-013754 5463
2021-07-12 3 FORM 3 0001628280-21-013753 3308
2021-07-12 8-K 8-K 5.02,8.01,9.01 0001628280-21-013733 001-35558 211084817 34 833434 1 1
2021-07-06 8-K 8-K 8.01,9.01 0001628280-21-013508 001-35558 211073264 34 699243 1 1
2021-06-28 8-K 8-K 8.01,9.01 0001628280-21-013021 001-35558 211052036 34 701456 1 1
2021-06-15 4 FORM 4 0001628280-21-012225 20113
2021-06-14 4 FORM 4 0001628280-21-012178 5333
2021-06-14 4 FORM 4 0001628280-21-012177 5396
2021-06-14 4 FORM 4 0001628280-21-012176 5299
2021-06-14 4 FORM 4 0001628280-21-012175 5417
2021-06-14 4 FORM 4 0001628280-21-012174 5342
2021-06-14 4 FORM 4 0001628280-21-012173 5433
2021-06-14 4 FORM 4 0001628280-21-012172 5483
2021-06-14 4 FORM 4 0001628280-21-012171 5346
2021-06-14 4 FORM 4 0001628280-21-012170 5315
2021-06-14 4 FORM 4 0001628280-21-012169 18052
2021-06-14 3 FORM 3 0001628280-21-012158 3294
2021-06-14 3 FORM 3 0001628280-21-012155 3315
2021-06-10 8-K 8-K 5.07,8.01,9.01 0001628280-21-012005 001-35558 211008122 34 376341
2021-06-10 S-8 S-8 0001628280-21-011993 333-256978 211008077 33 562461
2021-06-08 8-K 8-K 8.01,9.01 0001628280-21-011784 001-35558 211001316 34 348222
2021-06-01 8-K 8-K 7.01,9.01 0001628280-21-011401 001-35558 21983561 34 7548282
2021-05-27 4 FORM 4 0001628280-21-011230 4917
2021-05-20 8-K 8-K 8.01,9.01 0001628280-21-010750 001-35558 21942955 34 339700
2021-05-06 8-K 8-K 2.02,9.01 0001628280-21-009284 001-35558 21897559 34 375109
2021-05-06 10-Q 10-Q 0001628280-21-009283 001-35558 21897541 34 5232906 1 1
2021-04-28 DEFA14A DEFA14A 0001628280-21-007920 001-35558 21864151 34 423572
2021-04-28 DEF 14A DEF 14A 0001628280-21-007919 001-35558 21864122 34 583143
2021-04-12 8-K 8-K 7.01,8.01,9.01 0001628280-21-006756 001-35558 21819484 34 8254382
2021-04-08 8-K 8-K 8.01,9.01 0001628280-21-006707 001-35558 21814770 34 344133
2021-03-29 4 FORM 4 0001628280-21-005926 5500
2021-03-24 4 FORM 4 0001628280-21-005426 7390
2021-03-23 4 FORM 4 0001628280-21-005358 5897
2021-03-23 4 FORM 4 0001628280-21-005343 4651
2021-03-23 4 FORM 4 0001628280-21-005335 4703
2021-03-22 4 FORM 4 0001628280-21-005297 4708
2021-03-19 4 FORM 4 0001628280-21-005156 6026
2021-03-12 S-3ASR S-3ASR 0001628280-21-004640 333-254217 21737511 33 1955316
2021-03-11 8-K 8-K 8.01,9.01 0001628280-21-004508 001-35558 21732725 34 364112
2021-03-04 4 FORM 4 0001628280-21-003990 4662
2021-03-03 8-K 8-K 8.01,9.01 0001628280-21-003831 001-35558 21707996 34 336971
2021-02-25 8-K 8-K 2.02,9.01 0001628280-21-003278 001-35558 21680163 34 400790
2021-02-25 10-K 10-K 0001628280-21-003277 001-35558 21680143 34 8464403 1 1
2021-02-24 8-K 8-K 8.01,9.01 0001628280-21-002984 001-35558 21669989 34 340130
2021-02-16 SC 13G/A d8800257_13g-a.htm 0000919574-21-001548 005-80378 21637126 34 133632
2021-02-16 8-K 8-K 8.01,9.01 0001628280-21-002232 001-35558 21635777 34 339525
2021-02-16 SC 13G SC 13G 0001193125-21-043166 005-80378 21631972 34 82911
2021-02-12 SC 13G/A sc13ga.htm 0001493152-21-003709 005-80378 21629761 34 178804
2021-02-12 SC 13G JANUS HENDERSON GROUP PLC OWNS >5% 0001274173-21-000077 005-80378 21626201 34 7986
2021-02-11 SC 13G Cardiff_Oncology_Inc.txt 0000093751-21-000290 005-80378 21618215 34 10430
2021-02-11 8-K 8-K 8.01,9.01 0001628280-21-001908 001-35558 21617445 34 359605
2021-02-10 SC 13G/A SC 13G/A 0001104659-21-019876 005-80378 21614641 34 62060
2021-02-02 SC 13G d8790578_13-g.htm 0000919574-21-000616 005-80378 21578111 34 198759
2021-01-26 8-K 8-K 8.01,9.01 0001628280-21-000813 001-35558 21552311 34 347322
2021-01-15 8-K 8-K 8.01,9.01 0001628280-21-000474 001-35558 21530945 34 363805
2021-01-05 4 FORM 4 0001628280-21-000061 9257
2021-01-05 4 FORM 4 0001628280-21-000060 9318
2020-12-21 8-K 8-K 5.02,7.01,9.01 0001628280-20-017686 001-35558 201404537 34 392816
2020-12-07 8-K 8-K 8.01,9.01 0001628280-20-017151 001-35558 201372145 34 348984
2020-11-25 4 FORM 4 0001628280-20-016822 8571
2020-11-23 8-K 8-K 8.01,9.01 0001628280-20-016701 001-35558 201335476 34 340106
2020-11-05 8-K 8-K 2.02,9.01 0001628280-20-015736 001-35558 201290501 34 612995
2020-11-05 10-Q 10-Q 0001628280-20-015726 001-35558 201290287 34 6551686 1 1
2020-11-04 SC 13G SC 13G 0001104659-20-121396 005-80378 201287374 34 224517
2020-10-20 8-K 8-K 8.01,9.01 0001628280-20-014591 001-35558 201247742 34 369556
2020-10-09 SC 13G SCHEDULE 13G 0001104659-20-113928 005-80378 201233473 34 72141
2020-10-02 3 OWNERSHIP DOCUMENT 0001104659-20-111721 8577
2020-09-30 8-K 8-K 1.01,8.01,9.01 0001628280-20-014034 001-35558 201212355 34 817879
2020-09-30 424B5 424B5 0001628280-20-014029 333-232321 201212260 33 963736
2020-09-29 424B5 424B5 0001628280-20-013963 333-232321 201208884 33 953861
2020-09-22 8-K 8-K 7.01,9.01 0001628280-20-013800 001-35558 201187539 34 5520018
2020-09-17 8-K 8-K 8.01,9.01 0001628280-20-013690 001-35558 201180457 34 368101
2020-09-17 4 FORM 4 0001628280-20-013688 6024
2020-09-15 8-K 8-K 8.01,9.01 0001628280-20-013580 001-35558 201175155 34 357966
2020-09-14 8-K 8-K 8.01,9.01 0001628280-20-013539 001-35558 201172728 34 358787
2020-08-28 SC 13G sc13-g.htm 0001493152-20-016949 005-80378 201148722 34 172665
2020-08-11 8-K 8-K 2.02,9.01 0001628280-20-012429 001-35558 201092415 34 685407
2020-08-11 10-Q 10-Q 0001628280-20-012428 001-35558 201092375 34 7302351 1 1
2020-08-04 8-K 8-K 8.01,9.01 0001628280-20-011606 001-35558 201072755 34 351064
2020-07-30 8-K 8-K 8.01,9.01 0001628280-20-010960 001-35558 201060033 34 345549
2020-07-13 424B3 424B3 0001628280-20-010308 333-239464 201025286 33 650481
2020-07-10 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-07-10 16:00:00 9999999995-20-001766 333-239464 201024202 33 1963
2020-07-09 CORRESP filename1.htm 0001104659-20-082329 9407
2020-07-07 S-8 S-8 0001628280-20-010239 333-239725 201016177 33 388746
2020-07-06 S-1/A S-1/A 0001628280-20-010210 333-239464 201013522 33 877938
2020-07-02 SC 13D SC 13D 0001193125-20-186682 005-80378 201008720 34 111579
2020-07-02 UPLOAD filename1.pdf 0000000000-20-005962 40345
2020-06-26 S-1 S-1 0001628280-20-009971 333-239464 20994068 33 1285684
2020-06-23 D xslFormDX01/primary_doc.xml 06b 0001104659-20-075886 021-369462 20980526 33 11402
2020-06-22 3 3 0001104659-20-075737 11503
2020-06-22 SC 13G d8561646_13-g.htm 0000919574-20-004248 005-80378 20979360 34 127662
2020-06-19 4 4 0001104659-20-075244 5201
2020-06-19 4 4 0001104659-20-075242 5217
2020-06-19 4 4 0001104659-20-075240 5232
2020-06-19 4 4 0001104659-20-075238 5245
2020-06-19 4 4 0001104659-20-075237 5070
2020-06-19 4 4 0001104659-20-075234 5393
2020-06-19 4 4 0001104659-20-075232 5243
2020-06-19 4 4 0001104659-20-075230 5263
2020-06-19 8-K 8-K 5.02 0001628280-20-009689 001-35558 20974398 34 265922
2020-06-17 424B5 424B5 0001628280-20-009580 333-232321 20968788 33 1040307
2020-06-17 8-K/A 8-K/A 8.01 0001628280-20-009569 001-35558 20967542 34 267006
2020-06-16 8-K 8-K 1.01,3.02,5.03,8.01,9.01 0001628280-20-009534 001-35558 20966754 34 1208865
2020-06-15 8-K 8-K 8.01,9.01 0001628280-20-009417 001-35558 20962350 34 371474
2020-06-09 8-K 8-K 8.01,9.01 0001628280-20-009155 001-35558 20951287 34 363137
2020-06-04 SC 13G SC 13G 0001193125-20-160712 005-80378 20943093 34 103294
2020-06-03 424B3 424B3 0001628280-20-008898 333-238623 20939939 33 674567
2020-06-02 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-06-02 09:00:00 9999999995-20-001317 333-238623 20938852 33 1962
2020-06-01 D xslFormDX01/primary_doc.xml 06b 0001104659-20-068318 021-368047 20933294 33 11255
2020-05-29 UPLOAD filename1.pdf 0000000000-20-004799 40449
2020-05-29 CORRESP filename1.htm 0001104659-20-067639 11262
2020-05-29 8-K 8-K 8.01,9.01 0001628280-20-008589 001-35558 20925407 34 366370
2020-05-28 8-K 8-K 8.01,9.01 0001628280-20-008504 001-35558 20918929 34 364049
2020-05-27 424B5 424B5 0001104659-20-066429 333-232321 20915544 33 420236
2020-05-27 8-K 8-K 1.01,3.02,8.01,9.01 0001628280-20-008455 001-35558 20913756 34 971240
2020-05-22 S-1 S-1 0001628280-20-008292 333-238623 20906430 33 1322345
2020-05-21 D xslFormDX01/primary_doc.xml 06b 0001104659-20-064742 021-367488 20901875 33 11118
2020-05-19 8-K 8-K 1.01,3.02,9.01 0001628280-20-008004 001-35558 20891839 34 476957
2020-05-18 4 4 0001104659-20-063184 4644
2020-05-18 4 4 0001104659-20-063181 4865
2020-05-18 4 4 0001104659-20-063179 4611
2020-05-18 4 4 0001104659-20-063177 4438
2020-05-18 4 4 0001104659-20-063176 4714
2020-05-18 4 4 0001104659-20-063174 4585
2020-05-18 4 4 0001104659-20-063173 4448
2020-05-13 4 4 0001104659-20-060862 4685
2020-05-13 8-K 8-K 1.01,3.02,5.03,8.01,9.01 0001628280-20-007644 001-35558 20871565 34 332042
2020-05-07 10-Q 10-Q 0001628280-20-006938 001-35558 20856266 34 4501000 1
2020-05-07 8-K 8-K 2.02,9.01 0001628280-20-006933 001-35558 20856187 34 172737
2020-05-06 8-K 8-K 5.02,5.03,8.01,9.01 0001628280-20-006555 001-35558 20851560 34 78841
2020-05-01 4 4 0001104659-20-055492 5318
2020-05-01 4 4 0001104659-20-055491 5334
2020-05-01 4 4 0001104659-20-055489 5349
2020-04-30 3 3 0001104659-20-054721 3051
2020-04-28 8-K 8-K 8.01,9.01 0001628280-20-005682 001-35558 20823500 34 72471
2020-04-22 3 3 0001104659-20-049722 3039
2020-04-22 3 3 0001104659-20-049719 3020
2020-04-22 8-K 8-K 8.01,9.01 0001628280-20-005226 001-35558 20806959 34 56488
2020-04-17 8-K 8-K 1.01,2.03 0001628280-20-005112 001-35558 20799668 34 31007
2020-04-17 8-K 8-K 5.07 0001628280-20-005079 001-35558 20797409 34 57286
2020-04-14 D xslFormDX01/primary_doc.xml 06b 0001104659-20-046083 021-364879 20789789 33 11264
2020-04-10 424B5 424B5 0001104659-20-045585 333-232321 20787141 33 447936
2020-04-10 8-K FORM 8-K 1.01,3.02,9.01 0001104659-20-045549 001-35558 20786835 34 661924
2020-04-08 8-K 8-K 8.01,9.01 0001628280-20-004781 001-35558 20781442 34 52244
2020-04-01 8-K 8-K 8.01,9.01 0001628280-20-004445 001-35558 20764732 34 61438
2020-03-31 424B5 424B5 0001104659-20-041264 333-232321 20762800 33 452688
2020-03-31 8-K FORM 8-K 1.01,3.02,9.01 0001104659-20-041147 001-35558 20761830 34 662247
2020-03-05 8-K 8-K 8.01,9.01 0001628280-20-003017 001-35558 20689922 34 61382
2020-03-04 DEF 14A DEF 14A 0001104659-20-029280 001-35558 20688488 34 428476
2020-02-27 8-K 8-K 2.02,9.01 0001628280-20-002429 001-35558 20662212 34 223484
2020-02-27 10-K 10-K 0001628280-20-002424 001-35558 20661937 34 8097919 1
2020-02-14 SC 13G/A d8477686_sc13g-a.htm 0000919574-20-001613 005-80378 20618279 34 70569
2020-02-13 8-K 8-K 8.01,9.01 0001628280-20-001467 001-35558 20607415 34 91045
2020-02-06 SC 13G/A sc13ga310022002_02062020.htm 0000921895-20-000290 005-80378 20583119 34 222470
2020-02-05 8-K 8-K 8.01,9.01 0001628280-20-001027 001-35558 20576651 34 62514
2020-01-30 8-K 8-K 5.02 0001628280-20-000797 001-35558 20561786 34 29383
2020-01-29 8-K 8-K 8.01,9.01 0001628280-20-000651 001-35558 20556895 34 54936
2020-01-27 8-K 8-K 8.01,9.01 0001628280-20-000533 001-35558 20547707 34 73039
2020-01-21 8-K 8-K 8.01,9.01 0001628280-20-000403 001-35558 20535391 34 63255
2020-01-13 8-K trov8-k011320.htm 7.01,9.01 0001628280-20-000311 001-35558 20523104 34 5012688
2020-01-03 4 4 0001104659-20-000881 9510
2020-01-03 4 4 0001104659-20-000872 9511
2019-12-09 8-K 8-K 8.01,9.01 0001628280-19-014850 001-35558 191275057 34 77801
2019-12-04 8-K 8-K 8.01,9.01 0001628280-19-014717 001-35558 191267744 34 64186
2019-11-14 424B3 424B3 0001104659-19-063977 333-234442 191218140 33 200871
2019-11-14 8-K 8-K 8.01,9.01 0001628280-19-014171 001-35558 191216761 34 66362
2019-11-13 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2019-11-13 17:00:00 9999999995-19-002565 333-234442 191216109 33 1952
2019-11-12 UPLOAD filename1.pdf 0000000000-19-015417 40102
2019-11-12 CORRESP filename1.htm 0001104659-19-062115 10762

Latest XBRL company facts

One latest value per concept from companyfacts (377 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 77.80M 2026-11-03 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
dei EntityPublicFloat Entity Public Float USD 205.40M 2025-06-30 2025 FY 10-K 2026-02-24 0001193125-26-067464
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 884,143 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001213037-26-000006
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.91M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001213037-26-000006
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 890,939 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001213037-26-000006
ecd PeoTotalCompAmt PeoTotalCompAmt USD 3.02M 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001213037-26-000006
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 201 2025-01-01 2025-12-31 DEF 14A 2026-04-23 0001213037-26-000006
ffd NetFeeAmt NetFeeAmt USD 573.68 2026-07-21 S-8 2026-07-21 0001193125-26-310273
ffd TtlFeeAmt TtlFeeAmt USD 573.68 2026-07-21 S-8 2026-07-21 0001193125-26-310273
ffd TtlOfferingAmt TtlOfferingAmt USD 4.15M 2026-07-21 S-8 2026-07-21 0001193125-26-310273
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-07-21 S-8 2026-07-21 0001193125-26-310273
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 693,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 90,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 181,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap AccretionOfDiscount Accretion of Discount (Deprecated 2016-01-31) USD 68,223 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-10 0001628280-17-005344
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 7.36M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 29,000 2022-09-30 2022 Q3 10-Q 2022-11-03 0001628280-22-028164
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 4.38M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -112,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 488.67M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.34M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 301,499 2004-02-01 2005-01-31 2013 FY 10-K 2014-03-17 0001104659-14-020261
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 55,568 2006-02-01 2007-01-31 2012 Q3 10-Q 2012-11-14 0001104659-12-077744
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 3.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001628280-19-002546
us-gaap AmortizationOfDeferredLeasingFees Amortization of Deferred Leasing Fees USD -136,776 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-09 0001628280-17-008455
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 2.35M 1999-08-04 2014-03-31 2014 Q1 10-Q 2014-05-12 0001104659-14-037604
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 20.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap AreaOfLand Area of Land sqft 26,100 2018-09-30 2018 Q3 10-Q 2018-11-07 0001628280-18-013880
us-gaap Assets Assets USD 36.41M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap AssetsCurrent Assets, Current USD 35.03M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 113,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 21.84M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 24.38M 2016-09-30 2016 Q3 10-Q 2016-11-09 0001628280-16-021098
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 374 2016-12-31 2017 FY 10-K 2018-02-26 0001628280-18-002226
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 9,439 2016-12-31 2017 FY 10-K 2018-02-26 0001628280-18-002226
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 23.99M 2016-12-31 2017 FY 10-K 2018-02-26 0001628280-18-002226
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 21.73M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 15.65M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 6.08M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001628280-19-002546
us-gaap AvailableForSaleSecuritiesGrossRealizedGainLossNet Available-for-sale Securities, Gross Realized Gain (Loss) USD 6,400 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-26 0001628280-18-002226
us-gaap AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCost Available-for-sale Securities, Short-term Investments, Amortized Cost (Deprecated 2018-01-31) USD 23.99M 2016-12-31 2017 Q3 10-Q 2017-11-09 0001628280-17-011252
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 2,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-344545
us-gaap Cash Cash USD 8.60M 2013-05-10 2013 Q1 10-Q 2013-05-14 0001104659-13-041327
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 12.06M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 33.80M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 12.06M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -5.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/shares_unit 4.61 2012-09-30 2012 Q3 10-Q 2012-11-14 0001104659-12-077744
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 3.05 2020-06-15 2022 FY 10-K 2023-03-02 0001628280-23-006037
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 2.21M 2020-06-15 2022 FY 10-K 2023-03-02 0001628280-23-006037
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 9.76M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap CommercialPaper Commercial Paper USD 8.49M 2016-09-30 2016 Q3 10-Q 2016-11-09 0001628280-16-021098
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 150.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 77.80M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 77.80M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap CommonStockValue Common Stock, Value, Issued USD 8,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -30.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 886 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001628280-19-002546
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 1.34M 2022-10-01 2022-10-31 2022 FY 10-K 2023-03-02 0001628280-23-006037
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 863,852 2021-12-31 2022 FY 10-K 2023-03-02 0001628280-23-006037
us-gaap CostOfRevenue Cost of Revenue USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap CostsAndExpenses Costs and Expenses USD 10.67M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-06 0001104659-14-077681
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap DebtAndCapitalLeaseObligations Debt and Lease Obligation USD 15.00M 2013-12-31 2014 FY 10-K 2015-03-12 0001104659-15-019213
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 2.34M 1999-08-04 2014-03-31 2014 Q1 10-Q 2014-05-12 0001104659-14-037604
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.06 2014-03-31 2014 Q1 10-Q 2014-05-12 0001104659-14-037604
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostCurrent Debt Securities, Available-for-sale, Amortized Cost, Current USD 15.70M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent Debt Securities, Available-for-sale, Amortized Cost, Noncurrent USD 6.14M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123242
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 0 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123242
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions Investments 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap DebtSecuritiesAvailableForSaleRealizedLoss Debt Securities, Available-for-sale, Realized Loss USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -8.62M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-26 0001628280-18-002226
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -8.83M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 136,000 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap DeferredRentCredit Deferred Rent Credit USD 1.86M 2016-04-04 2016 Q3 10-Q 2016-11-09 0001628280-16-021098
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 0 2019-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 0 2019-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -213,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 57.40M 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap DeferredTaxAssetsGrossCurrent Deferred Tax Assets, Gross, Current USD 43.99M 2019-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 17.60M 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 31.98M 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 1.31M 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.65M 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 57.26M 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap DeferredTaxAssetsValuationAllowanceCurrent Deferred Tax Assets, Valuation Allowance, Current USD 43.82M 2019-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2018-12-31 2018 FY 10-K 2019-03-06 0001628280-19-002546
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 136,000 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 0 2022-12-31 2022 FY 10-K 2023-03-02 0001628280-23-006037
us-gaap Depreciation Depreciation USD 262,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 262,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 0 2021-12-31 2021 FY 10-K 2022-02-24 0001628280-22-003808
us-gaap DisposalGroupNotDiscontinuedOperationGainLossOnDisposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal USD -52,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 6,000 2022-07-01 2022-09-30 2023 Q3 10-Q 2023-11-02 0001628280-23-036375
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.43 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.14 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-06 0001628280-21-009283
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.43 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.188 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001628280-19-002546
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-26 0001628280-18-002226
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.009 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 432,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.009 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.013 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001628280-19-002546
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 2.91M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions Share-based Payment Arrangement, Exercise of Option, Tax Benefit USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001628280-19-002546
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-15 0001628280-17-002601
us-gaap EquityIssuancePerShareAmount Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) USD 0.003 2002-02-01 2003-01-31 2013 FY 10-K 2014-03-17 0001104659-14-020261
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 1.43M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-12 0001104659-15-019213
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 3.01M 2014-12-31 2014 FY 10-K 2015-03-12 0001104659-15-019213
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001628280-24-007948
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-09 0001628280-16-021098
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 11.50M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-26 0001628280-18-002226
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -45.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -45.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap IncomeTaxesPaid Income Taxes Paid USD 1,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001628280-24-007948
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 8.62M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001628280-19-002546
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-26 0001628280-18-002226
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -9.63M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 5,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 400,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -408,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 591,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -7.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -92,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap IncreaseDecreaseInAccruedInvestmentIncomeReceivable Increase (Decrease) in Accrued Investment Income Receivable USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001628280-19-002546
us-gaap IncreaseDecreaseInDeferredCharges Increase (Decrease) in Deferred Charges USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 2,085 2013-01-01 2013-09-30 2014 Q3 10-Q 2014-11-06 0001104659-14-077681
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -567,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 0 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-10 0001628280-17-005344
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 250,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001628280-24-007948
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -438,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-07 0001628280-18-013880
us-gaap InterestExpense Interest Expense USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001628280-22-003808
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 32,812 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-03 0001628280-18-010424
us-gaap InterestIncomeOperating Interest Income, Operating USD 926,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-02 0001628280-24-019974
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 0 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001628280-19-010441
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2018-12-31 2018 FY 10-K 2019-03-06 0001628280-19-002546
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 300,000 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap InvestmentIncomeNet Investment Income, Net USD 57,261 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-10 0001628280-16-012562
us-gaap LeaseCost Lease, Cost USD 667,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-028992
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 866,000 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 136,000 2021-12-31 2021 FY 10-K 2022-02-24 0001628280-22-003808
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 730,000 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 796,000 2021-12-31 2021 FY 10-K 2022-02-24 0001628280-22-003808
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 136,000 2023-12-31 2023 FY 10-K 2024-02-29 0001628280-24-007948
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 136,000 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-028992
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 136,000 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 306,000 2023-06-30 2023 Q2 10-Q 2023-08-09 0001628280-23-028549
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 34,000 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap LessorOperatingLeasePaymentsToBeReceived Lessor, Operating Lease, Payments to be Received USD 101,000 2021-09-30 2021 Q3 10-Q 2021-11-04 0001628280-21-021747
us-gaap LessorOperatingLeasePaymentsToBeReceivedFiveYears Lessor, Operating Lease, Payment to be Received, Year Five USD 0 2019-09-30 2019 Q3 10-Q 2019-11-07 0001628280-19-013646
us-gaap LessorOperatingLeasePaymentsToBeReceivedFourYears Lessor, Operating Lease, Payment to be Received, Year Four USD 0 2021-09-30 2021 Q3 10-Q 2021-11-04 0001628280-21-021747
us-gaap LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths Lessor, Operating Lease, Payment to be Received, Year One USD 0 2021-09-30 2021 Q3 10-Q 2021-11-04 0001628280-21-021747
us-gaap LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year USD 101,000 2021-09-30 2021 Q3 10-Q 2021-11-04 0001628280-21-021747
us-gaap LessorOperatingLeasePaymentsToBeReceivedThreeYears Lessor, Operating Lease, Payment to be Received, Year Three USD 0 2021-09-30 2021 Q3 10-Q 2021-11-04 0001628280-21-021747
us-gaap LessorOperatingLeasePaymentsToBeReceivedTwoYears Lessor, Operating Lease, Payment to be Received, Year Two USD 0 2021-09-30 2021 Q3 10-Q 2021-11-04 0001628280-21-021747
us-gaap Liabilities Liabilities USD 8.32M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 36.41M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap LiabilitiesCurrent Liabilities, Current USD 8.32M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap LicenseAndServicesRevenue License and Services Revenue (Deprecated 2018-01-31) USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-15 0001628280-17-002601
us-gaap LineOfCredit Long-term Line of Credit USD 1.88M 2016-09-30 2016 Q3 10-Q 2016-11-09 0001628280-16-021098
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 1.33M 2017-12-31 2017 FY 10-K 2018-02-26 0001628280-18-002226
us-gaap LitigationReserve Estimated Litigation Liability USD 2.10M 2017-12-31 2017 FY 10-K 2018-02-26 0001628280-18-002226
us-gaap LongTermDebtAndCapitalLeaseObligations Long-term Debt and Lease Obligation USD 0 2017-12-31 2017 FY 10-K 2018-02-26 0001628280-18-002226
us-gaap LongTermDebtAndCapitalLeaseObligationsCurrent Long-term Debt and Lease Obligation, Current USD 0 2018-12-31 2018 FY 10-K 2019-03-06 0001628280-19-002546
us-gaap LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four USD 3.17M 2013-12-31 2014 FY 10-K 2015-03-12 0001104659-15-019213
us-gaap LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three USD 5.14M 2013-12-31 2014 FY 10-K 2015-03-12 0001104659-15-019213
us-gaap LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two USD 4.79M 2013-12-31 2014 FY 10-K 2015-03-12 0001104659-15-019213
us-gaap LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths Long-term Debt and Capital Lease Obligations, Repayments of Principal in Next Twelve Months USD 1.90M 2013-12-31 2014 FY 10-K 2015-03-12 0001104659-15-019213
us-gaap LongTermLineOfCredit Long-term Line of Credit, Noncurrent USD 1.08M 2017-03-31 2017 Q1 10-Q 2017-05-10 0001628280-17-005344
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 234,270 2020-06-30 2020 Q2 10-Q 2020-08-11 0001628280-20-012428
us-gaap NetCashProvidedByUsedInContinuingOperations Net Cash Provided by (Used in) Continuing Operations USD -661,863 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001628280-19-010441
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 9.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 6.15M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001628280-19-010441
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 19.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -5,274 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001628280-19-010441
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -33.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -6.80M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001628280-19-010441
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -30.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -30.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -11.95M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-05 0001628280-21-015834
us-gaap NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification (Deprecated 2020-01-31) USD 109,922 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnNetIncome New Accounting Pronouncement or Change in Accounting Principle, Effect of Change on Net Income (Deprecated 2020-01-31) USD -455,385 1999-08-04 2014-03-31 2014 Q1 10-Q 2014-05-12 0001104659-14-037604
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 1.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap NotesPayableCurrent Notes Payable, Current USD 305,000 2020-09-30 2020 Q3 10-Q 2020-11-05 0001628280-20-015726
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap OperatingExpenses Operating Expenses USD 32.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -31.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap OperatingLeaseCost Operating Lease, Cost USD 620,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001628280-21-021747
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 832,000 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 265,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap OperatingLeasePayments Operating Lease, Payments USD 777,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 225,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 404,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 2.83M 2018-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 914,540 2018-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 3,423 2018-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 5,868 2018-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 968,165 2018-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 941,670 2018-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 0 2017-12-31 2017 FY 10-K 2018-02-26 0001628280-18-002226
us-gaap OperatingLeasesFutureMinimumPaymentsReceivable Operating Leases, Future Minimum Payments Receivable USD 333,124 2018-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableCurrent Operating Leases, Future Minimum Payments Receivable, Current USD 333,124 2018-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears Operating Leases, Future Minimum Payments Receivable, in Five Years USD 0 2018-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInFourYears Operating Leases, Future Minimum Payments Receivable, in Four Years USD 0 2018-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears Operating Leases, Future Minimum Payments Receivable, in Three Years USD 0 2018-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears Operating Leases, Future Minimum Payments Receivable, in Two Years USD 0 2018-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableThereafter Operating Leases, Future Minimum Payments Receivable, Thereafter USD 0 2017-12-31 2017 FY 10-K 2018-02-26 0001628280-18-002226
us-gaap OperatingLeasesIncomeStatementSubleaseRevenue Operating Leases, Income Statement, Sublease Revenue USD 306,066 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-15 0001628280-17-002601
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 731,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001628280-19-002546
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.07 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 434,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 799,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001628280-19-002546
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -162,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -50,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001628280-19-002546
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 0 2022-12-31 2022 FY 10-K 2023-03-02 0001628280-23-006037
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2021-12-31 2021 FY 10-K 2022-02-24 0001628280-22-003808
us-gaap OtherNonoperatingGainsLosses Other Nonoperating Gains (Losses) USD -98,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001628280-24-007948
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD -28,244 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001628280-21-003277
us-gaap OtherSalesRevenueNet Other Revenue, Net (Deprecated 2018-01-31) USD 42,614 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-07 0001628280-18-013880
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 757,198 1999-08-04 2014-03-31 2014 Q1 10-Q 2014-05-12 0001104659-14-037604
us-gaap PaymentsForFees Payments for Other Fees USD 0 2016-03-01 2016-12-31 2016 FY 10-K 2017-03-15 0001628280-17-002601
us-gaap PaymentsForLegalSettlements Payments for Legal Settlements USD 400,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap PaymentsForProceedsFromShortTermInvestments Payments for (Proceeds from) Short-term Investments USD 24.45M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-09 0001628280-16-021098
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 500,000 1999-08-04 2014-03-31 2014 Q1 10-Q 2014-05-12 0001104659-14-037604
us-gaap PaymentsForRepurchaseOfWarrants Payments for Repurchase of Warrants USD 169,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001628280-22-003808
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 297,104 1999-08-04 2014-03-31 2014 Q1 10-Q 2014-05-12 0001104659-14-037604
us-gaap PaymentsOfDividendsPreferredStockAndPreferenceStock Payments of Ordinary Dividends, Preferred Stock and Preference Stock USD 116,718 1999-08-04 2014-03-31 2014 Q1 10-Q 2014-05-12 0001104659-14-037604
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 15.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 104,700 1999-08-04 2014-03-31 2014 Q1 10-Q 2014-05-12 0001104659-14-037604
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 48,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap PreferredStockAccretionOfRedemptionDiscount Preferred Stock, Accretion of Redemption Discount USD 792,956 1999-08-04 2014-03-31 2014 Q1 10-Q 2014-05-12 0001104659-14-037604
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 18,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 1.14M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 20.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 60,600 2018-03-31 2018 Q1 10-Q 2018-05-08 0001628280-18-006233
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 2.30M 2023-12-31 2023 FY 10-K 2024-02-29 0001628280-24-007948
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 1.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 2.34M 1999-08-04 2014-03-31 2014 Q1 10-Q 2014-05-12 0001104659-14-037604
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 0 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-09 0001628280-17-011252
us-gaap ProceedsFromInsuranceSettlementInvestingActivities Proceeds from Insurance Settlement, Investing Activities USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001628280-24-007948
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 212,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-344545
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001628280-22-003808
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 2.77M 1999-08-04 2014-03-31 2014 Q1 10-Q 2014-05-12 0001104659-14-037604
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001628280-19-002546
us-gaap ProceedsFromLongTermCapitalLeaseObligations Proceeds from Long-term Capital Lease Obligations USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-09 0001628280-15-008551
us-gaap ProceedsFromLongTermLinesOfCredit Proceeds from Long-term Lines of Credit USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-26 0001628280-18-002226
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 32.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001628280-22-003808
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001628280-19-002546
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 2.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 106,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 2.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 4.75M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 364,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-09 0001628280-15-008551
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001628280-19-002546
us-gaap RepaymentsOfLongTermLinesOfCredit Repayments of Long-term Lines of Credit USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 27.10M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-02 0001628280-23-006037
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 17.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 2.67M 1999-08-04 2014-03-31 2014 Q1 10-Q 2014-05-12 0001104659-14-037604
us-gaap RestructuringAndRelatedCostExpectedCost1 Restructuring and Related Cost, Expected Cost USD 2.00M 2017-09-30 2017 Q3 10-Q 2017-11-09 0001628280-17-011252
us-gaap RestructuringCharges Restructuring Charges USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap RestructuringCostsAndAssetImpairmentCharges Restructuring Costs and Asset Impairment Charges USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001628280-22-003808
us-gaap RestructuringReserve Restructuring Reserve USD 262,000 2017-12-31 2017 FY 10-K 2018-02-26 0001628280-18-002226
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -460.46M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 316,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap RevenueNotFromContractWithCustomer Revenue Not from Contract with Customer USD 0 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001628280-20-015726
us-gaap RevenueRecognitionMilestoneMethodRevenueRecognized Revenue Recognition, Milestone Method, Revenue Recognized USD 150,000 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-12 0001104659-15-019213
us-gaap Revenues Revenues USD 226,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001628280-21-021747
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-02 0001628280-23-006037
us-gaap RoyaltyRevenue Royalty Revenue (Deprecated 2018-01-31) USD 62,021 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-07 0001628280-19-006051
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 34.19M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-02 0001628280-23-006037
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 3.90M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123242
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 13.5 2020-10-02 2021 FY 10-K 2022-02-24 0001628280-22-003808
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 161,958 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-07 0001628280-19-006051
us-gaap SalesRevenueServicesNet Sales Revenue, Services, Net (Deprecated 2018-01-31) USD 99,937 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-07 0001628280-19-006051
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 2.74M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-26 0001628280-18-002226
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 14.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 3.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 100,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0001628280-24-007948
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested USD 295,368 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001628280-19-002546
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 15.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 333,955 2012-09-30 2012 Q3 10-Q 2012-11-14 0001104659-12-077744
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.65M 2012-09-30 2012 Q3 10-Q 2012-11-14 0001104659-12-077744
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 6.23 2012-09-30 2012 Q3 10-Q 2012-11-14 0001104659-12-077744
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 1.00M 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-24 0001628280-22-003808
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 9,375 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001104659-12-077744
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.70M 2024-05-30 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 3.51 2024-05-30 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 265,774 2012-09-30 2012 Q3 10-Q 2012-11-14 0001104659-12-077744
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 3.30M 2012-09-30 2012 Q3 10-Q 2012-11-14 0001104659-12-077744
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 4.74 2012-09-30 2012 Q3 10-Q 2012-11-14 0001104659-12-077744
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 7.26M 2021-06-30 2021 Q2 10-Q 2021-08-05 0001628280-21-015834
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 2.89M 2021-06-30 2021 Q2 10-Q 2021-08-05 0001628280-21-015834
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 7.72 2021-06-30 2021 Q2 10-Q 2021-08-05 0001628280-21-015834
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 4.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 600,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0000950170-25-028992
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 3 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-12 0001104659-15-019213
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 3 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001104659-12-077744
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 3.46 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001104659-12-077744
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate pure 0 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-10 0001628280-16-012562
us-gaap SharesIssued Shares, Issued shares 61,000 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-269424
us-gaap ShortTermInvestments Short-term Investments USD 21.73M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 28.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap StockholdersEquityNoteStockSplitConversionRatio Stockholders' Equity Note, Stock Split, Conversion Ratio (Deprecated 2013-01-31) pure 0.167 2012-05-29 2012-05-30 2012 FY 10-K 2013-04-01 0001104659-13-026211
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.167 2012-05-29 2014 FY 10-K 2015-03-12 0001104659-15-019213
us-gaap StockIssued1 Stock Issued USD 1.74M 1999-08-04 2012-12-31 2012 FY 10-K 2013-04-01 0001104659-13-026211
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 125,000 1999-08-04 2012-06-30 2012 Q2 10-Q 2012-08-14 0001104659-12-057783
us-gaap StockIssuedDuringPeriodSharesIssuedForNoncashConsideration Development Stage Entities, Stock Issued, Shares, Issued for Noncash Consideration (Deprecated 2015-01-31) shares 41,750 1999-08-04 2013-12-31 2013 FY 10-K 2014-03-17 0001104659-14-020261
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 1.99M 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001628280-20-002424
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures shares 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-06 0001628280-19-002546
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 41,667 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-17 0001104659-14-020261
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 187,500 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001104659-12-077744
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD -1,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-02-29 0001628280-24-007948
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 1.47M 2009-01-01 2009-12-31 2013 FY 10-K 2014-03-17 0001104659-14-020261
us-gaap StockIssuedDuringPeriodValueIssuedForNoncashConsiderations Development Stage Entities, Stock Issued, Value, Issued for Noncash Consideration (Deprecated 2015-01-31) USD 22,381 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-12 0001104659-15-019213
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 9,566 2006-02-01 2007-01-31 2012 Q3 10-Q 2012-11-14 0001104659-12-077744
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 148,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD -8,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-24 0001628280-22-003808
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001628280-21-003277
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 125,250 2011-01-01 2011-12-31 2012 Q3 10-Q 2012-11-14 0001104659-12-077744
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 105,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD 500,000 2004-02-01 2005-01-31 2013 FY 10-K 2014-03-17 0001104659-14-020261
us-gaap StockRepurchasedAndRetiredDuringPeriodShares Stock Repurchased and Retired During Period, Shares shares 1.70M 2024-05-30 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 0 2005-02-01 2006-01-31 2013 FY 10-K 2014-03-17 0001104659-14-020261
us-gaap SubleaseIncome Sublease Income USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-02 0001628280-23-006037
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 277,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 61,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap TreasuryStockAcquiredAverageCostPerShare Treasury Stock Acquired, Average Cost Per Share USD/shares 3.51 2024-05-30 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-02 0001628280-23-006037
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 935,000 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 158,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 777,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001193125-26-067464
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 6.10M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-12 0001104659-15-019213
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 71.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 37.16M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-06 0001628280-21-009283
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 71.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458485

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →